A study involving NF-kB activation and overexpression of its regulated genes in patients with T2D revealed that the activation of NF-kB and the transcription of certain pro-inflammatory chemokines in tubular epithelial cells are markers of progressive diabetic nephropathy [71]. The gene discussed is NFKB1; the disease is diabetic kidney disease.